MedPath

Alberta Cancer Exercise Hybrid Effectiveness-Implementation Study

Not Applicable
Active, not recruiting
Conditions
Neoplasms
Interventions
Behavioral: Exercise
Registration Number
NCT02984163
Lead Sponsor
University of Alberta
Brief Summary

The primary purpose of this proposed 5-year hybrid effectiveness and implementation study is to evaluate the relative benefit from, and implementation of an Alberta wide clinic-to-community-based cancer and exercise model of care - the Alberta Cancer Exercise (ACE) Program. The investigators hypothesize that the strategy will improve the physical well-being and QoL of survivors (on and off cancer treatment) while preventing the development of secondary cancers.

Detailed Description

A total of 2500 adult cancer survivors will be enrolled in the 5-year study. The investigators will build capacity by expanding ACE training and programming to sites beyond the large urban centers. The investigators plan for implementation in 7 Alberta YMCAs and/or City Recreation facilities within 3 years, as well as to formally establish partnerships within AHS to build further capacity across the province within existing AHS programming (e.g., CancerControl Rehab Services, Alberta Healthy Living Program and Primary Care Network). Virtual and supported home-based options will be available as an alternative.

Eligible and consenting participants will be screened for exercise safety, and following fitness testing will be triaged to appropriate exercise programming in their home or community. The exercise intervention will take place at the survivor's home, YMCAs and municipal fitness centres across the province. The supported home-based and community-based exercise program will be administered by exercise specialists who have undergone the ACE Cancer and Exercise: Training for Fitness Professionals course. Survivors will take part in a combination of aerobic, resistance, balance, and flexibility exercises delivered in a circuit-type class setting or group personal training format, twice weekly for an 8-to-12-week period.

Effectiveness outcomes include physical fitness, physical activity, quality of life, and healthcare utilization. These outcomes are known factors associated with the secondary prevention of cancer. The RE-AIM framework will be used to evaluate program reach, effectiveness, adoption, implementation and maintenance. The Alberta Quality Matrix for Health will serve as a framework to inform program sustainability beyond the funding period. Through this research, the investigators will better understand the effectiveness of the ACE program, and evaluate processes to support future implementation and sustainability.

Recruitment & Eligibility

Status
ACTIVE_NOT_RECRUITING
Sex
All
Target Recruitment
2570
Inclusion Criteria
  1. have a diagnosis of cancer;
  2. be over the age of 18 years;
  3. be able to participate in low-intensity levels of activity at minimum;
  4. be pretreatment, or receiving active cancer treatment (i.e., surgery, systemic therapy and radiation therapy), or have received cancer treatment within the past 3 years; or have ongoing significant cancer or treatment-related impairments (requiring supportive exercise intervention);
  5. be able to provide informed written consent in English.

Exclusion criteria:

  1. Inability or deemed unsafe to participate in physical activity program
Read More
Exclusion Criteria

Not provided

Read More

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
Exercise InterventionExerciseParticipant exercise sessions will be conducted in groups of 10-15 under the direct supervision of the community-based exercise specialist. Sessions will be twice a week for 12-weeks. Participants will have the option to continue with the exercise program after the 12-weeks on a fee-for-service basis.
Primary Outcome Measures
NameTimeMethod
Physical Activity Minutes Per WeekBaseline to One-year

Change in number of participants meeting Guidelines for Physical Activity of 150 minutes per week of moderate intensity exercise

Secondary Outcome Measures
NameTimeMethod
General Health-related Quality of LifeBaseline to One-year

Change in Rand Short Form (SF)-36

Upper extremity grip strengthBaseline to One-year

Change in hand-grip dynamometry (kg)

Quality of Life Cancer SpecificBaseline to One year

Change in Functional Assessment of Cancer Therapy General Scale

Functional performance testBaseline to One-year

Change in sit-to-stand (number in 30 seconds)

Aerobic EnduranceBaseline to One-year

Change in 6 minute walk test distance (metres)

Upper extremity flexibilityBaseline to One-year

Change in active shoulder flexion range of motion (degrees)

Cost-effectiveness evaluationBaseline to One-year

EQ-5D questionnaire

Program implementation and evaluationBaseline to One-year

RE-AIM: program reach, effectiveness, adoption, implementation and maintenance

Lower extremity flexibilityBaseline to One-year

Change in sit-and-reach test (cm)

Exercise adherenceBaseline to 12-weeks

Adherence to exercise programming (attendance at sessions)

Body CompositionBaseline to One-year

Change in BMI

FatigueBaseline to One-year

FACT-Fatigue subscale

BalanceBaseline to One-year

Change in one legged stance test (seconds)

Waist and hip measurementsBaseline to One-year

Change in waist and hip circumference (cm) and change in waist-to-hip ratio

Adverse eventsBaseline to One-year

Adverse event rates

Trial Locations

Locations (2)

University of Calgary/ Tom Baker Cancer Centre

🇨🇦

Calgary, Alberta, Canada

University of Alberta & Cross Cancer Institute

🇨🇦

Edmonton, Alberta, Canada

© Copyright 2025. All Rights Reserved by MedPath